Europe Cell Line Development Market may exceed USD 2.1 billion by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Europe Cell Line Development Market may exceed USD 2.1 billion by 2024

Description:

Increasing prevalence of chronic diseases such as cancer will drive the Europe cell line development market. Cancer is one of the leading causes of morbidity and mortality in Europe. Extensive investment in R&D activities to reduce cancer burden in the region, will fuel need for cell line development for cancer treatment. – PowerPoint PPT presentation

Number of Views:26

less

Transcript and Presenter's Notes

Title: Europe Cell Line Development Market may exceed USD 2.1 billion by 2024


1

Europe Cell Line Development Market to reach USD
2.1bn by 2024 Graphical Research
2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
2

Key Insights from Europe Cell Line Development
Market
  • Graphical Research says, Europe Cell Line
    Development Market to reach USD 2.1bn by 2024
  • Growing disease burden across the globe is the
    key factor that will drive cell line development
    market growth.
  • Rising demand for vaccines and monoclonal
    antibodies in treatment of cancer, autoimmune
    diseases and anti-inflammatory disease will fuel
    demand for cell line cultures.
  • Developments in biotechnology industry,
    increasing healthcare expenditure coupled with
    growing adoption of technologically advanced
    products should accelerate the cell line
    development industry growth.
  • Technological advancements in cell line
    development products is another major contributor
    for cell line development business growth.
    Availability of automated screening methods,
    enriched medias, disposable equipment and
    improved expression systems for enhancing cell
    line development practices will foster market
    growth.

2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
3

Continued...
  • Reagents and media product segment accounted for
    largest market share of 53.6 in 2017 and is
    projected to show robust growth throughout the
    analysis period.
  • Mammalian cell cultures segment was valued at USD
    650.8 million in 2017 and is estimated to show
    similar growth during the forecast period.
  • Recombinant cell line type segment is anticipated
    to grow at 12.5 CAGR during the forthcoming
    years. Advent of rDNA technology has drastically
    increased the demand for recombinant cell lines
  • Germany cell line development market will grow
    considerably during the forecast period owing to
    increasing disease burden in the region. Growing
    adoption of vaccines and monoclonal antibodies
    will foster cell line development industry
    growth.
  • Key industry players operating in Europe cell
    line development market are Selexis, Sartorius,
    Lonza Group, Samsung Biologics, WuXi AppTec, GE
    Healthcare, Thermo Fisher Scientific, The
    European Collection of Cell Cultures,
    Sigma-Aldrich (Merck), GVK BIO, and Progenitor
    Cell Therapy.

2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
4

Browse Full Market Research Report On Europe Cell
Line Development Market _at_ https//bit.ly/2N4VHQC
Request for a Sample of this Research
Report _at_ https//bit.ly/2zs5k88
2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
5

Stay In Touch With Us For
Website www.graphicalresearch.com Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
reserved.


www.graphicalresearch.com
Write a Comment
User Comments (0)
About PowerShow.com